一项多中心前性匹配对癌症患者接受化疗的骨质疏松症风险的比较研究
Sabin Goktas Aydin1, Ahmet Aydin2, Burcin Cakan Demirel3
1Department of Medical Oncology, SBU Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey. drsabingoktas@gmail.com.
概括
癌症患者面临明显更高的骨质疏松症风险,超过21%的患者患有骨质疏松症,而健康人群中这一比例为2.3%. 这凸显了癌症幸存者骨健康监测的关键需求.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 癌症治疗和疾病本身加剧了骨质疏松症.
- 改善的癌症存活率增加了骨质疏松症的患病率.
- 在癌症患者中评估骨质疏松症风险对于患者护理至关重要.
研究的目的:
- 为了评估与健康对照组相比,化疗患者的骨质疏松症风险.
- 为了确定预测癌症患者骨质疏松症的因素.
- 了解癌症对骨矿物质密度的影响.
主要方法:
- 一项多中心前性,横截面研究,涉及257名癌症患者和257名匹配对照.
- 使用双能X射线吸收计 (DXA) 测量骨矿物质密度 (BMD).
- 倾向性得分匹配用于控制混变量; 应用了特定的排除.
主要成果:
- 癌症患者的骨质疏松和骨质疏松率在腰椎和股骨中显著更高.
- 在癌症患者中,腰部BMD降低了26.2%,大腿部BMD降低了9.2%.
- 维生素D缺乏症在癌症患者中更为普遍,并且与骨质量减少有关;癌症增加了骨质疏松症风险6.8倍.
结论:
- 对于癌症患者来说,骨健康管理对于提高生活质量至关重要.
- 在癌症幸存者中早期发现和干预骨质疏松症至关重要.
- 对预测因素和管理策略的进一步研究是有必要的.
相关概念视频
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Bioavailability Study Design: Healthy Subjects Versus Patients
137
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
137
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Comparing the Survival Analysis of Two or More Groups
542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542

